Matches in Wikidata for { <http://www.wikidata.org/entity/Q91190764> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q91190764 description "article scientifique publié en 2019" @default.
- Q91190764 description "articolo scientifico (pubblicato il 2019)" @default.
- Q91190764 description "artikull shkencor i botuar më 01 shkurt 2019" @default.
- Q91190764 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91190764 description "scientific article published on 01 February 2019" @default.
- Q91190764 description "wetenschappelijk artikel" @default.
- Q91190764 description "наукова стаття, опублікована 1 лютого 2019" @default.
- Q91190764 name "Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?" @default.
- Q91190764 name "Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?" @default.
- Q91190764 name "Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?" @default.
- Q91190764 type Item @default.
- Q91190764 label "Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?" @default.
- Q91190764 label "Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?" @default.
- Q91190764 label "Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?" @default.
- Q91190764 prefLabel "Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?" @default.
- Q91190764 prefLabel "Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?" @default.
- Q91190764 prefLabel "Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?" @default.
- Q91190764 P1433 Q91190764-C9E126D5-5D39-4DF7-9ED0-96F5B03B7848 @default.
- Q91190764 P1476 Q91190764-A2DED2B3-35B9-4DEF-8FC7-E8B207228F24 @default.
- Q91190764 P2093 Q91190764-2971B8C1-A36C-433D-8D1F-82F3D59014E1 @default.
- Q91190764 P2093 Q91190764-3DEEE793-84EA-4E17-BC50-CB597D15022C @default.
- Q91190764 P2093 Q91190764-44711497-A53F-48E1-9333-0E31BBE0B771 @default.
- Q91190764 P2093 Q91190764-53574F4F-1EAE-4DFF-8EBA-DA1192E853C5 @default.
- Q91190764 P2093 Q91190764-7081D85A-989C-447A-8461-2DE511866080 @default.
- Q91190764 P2093 Q91190764-816698C9-242B-4BA4-B5F4-5E9EBC480B20 @default.
- Q91190764 P2093 Q91190764-93E8E204-3375-4860-A0DE-D7AEC616CD7C @default.
- Q91190764 P2093 Q91190764-B8A873CA-C5D3-404B-934A-D54C48EBED20 @default.
- Q91190764 P2093 Q91190764-D4744748-81FF-477A-B6B9-C654D35F0C16 @default.
- Q91190764 P2093 Q91190764-DF1DE934-4FCA-4CC0-9A72-E992E788A9BF @default.
- Q91190764 P2093 Q91190764-FC611FD3-DC78-4FF9-9E90-1F5B6A60A467 @default.
- Q91190764 P304 Q91190764-4BDA3E4F-2E4D-4335-A9B4-2CF840816B90 @default.
- Q91190764 P31 Q91190764-EB8AECFE-8309-47C5-A1E5-6CBC38220BA4 @default.
- Q91190764 P356 Q91190764-1D626DCD-E733-4D11-8B91-9B9E6A3EE926 @default.
- Q91190764 P433 Q91190764-42334CBB-A138-44FA-9913-2F0DC827DEBE @default.
- Q91190764 P478 Q91190764-02324E84-7C53-4433-867F-F7AA8ED64BC4 @default.
- Q91190764 P50 Q91190764-62D94DA6-72DA-4FC2-83D7-D0F30DF6AAF0 @default.
- Q91190764 P50 Q91190764-6E5D3F79-BB44-4A78-A056-9CDA75C27FF6 @default.
- Q91190764 P50 Q91190764-D9096B25-4AE3-44B5-BA61-E3A2F260AAAD @default.
- Q91190764 P577 Q91190764-F17D94C3-9F7A-4537-876C-567892F8B0B3 @default.
- Q91190764 P698 Q91190764-A5316DD6-ED4C-44D3-89C0-A9B6728F21D1 @default.
- Q91190764 P921 Q91190764-86BA4787-B232-4F1D-A866-0AB0EFA94765 @default.
- Q91190764 P356 S10557-018-06850-0 @default.
- Q91190764 P698 30675708 @default.
- Q91190764 P1433 Q2473050 @default.
- Q91190764 P1476 "Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?" @default.
- Q91190764 P2093 "Alvaro Garcia-Ropero" @default.
- Q91190764 P2093 "Anu Lala" @default.
- Q91190764 P2093 "Carlos G Santos-Gallego" @default.
- Q91190764 P2093 "Farah Atallah-Lajam" @default.
- Q91190764 P2093 "Icilma Fergus" @default.
- Q91190764 P2093 "Javier Sanz" @default.
- Q91190764 P2093 "Johanna P Contreras" @default.
- Q91190764 P2093 "Pedro Moreno" @default.
- Q91190764 P2093 "Ronald Tamler" @default.
- Q91190764 P2093 "Sean P Pinney" @default.
- Q91190764 P2093 "Vivian Abascal" @default.
- Q91190764 P304 "87-95" @default.
- Q91190764 P31 Q13442814 @default.
- Q91190764 P356 "10.1007/S10557-018-06850-0" @default.
- Q91190764 P433 "1" @default.
- Q91190764 P478 "33" @default.
- Q91190764 P50 Q114359142 @default.
- Q91190764 P50 Q88427823 @default.
- Q91190764 P50 Q977751 @default.
- Q91190764 P577 "2019-02-01T00:00:00Z" @default.
- Q91190764 P698 "30675708" @default.
- Q91190764 P921 Q5373824 @default.